Marc Pocard

Hôpital Lariboisière, Sorbonne Université

Papers

2

Total Citations

19

H-Index

2

About

Marc Pocard is a leading French colorectal surgeon and researcher whose work centers on optimizing surgical strategies for rectal cancer, particularly through minimally invasive and organ-preserving approaches. His major contribution is the GRECCAR 2 randomized phase 3 trial, which compared local excision versus total mesorectal excision in patients with T2-T3 low rectal cancer who showed good response after neoadjuvant radiochemotherapy. This landmark study, cited over 14 times, provided critical evidence that local excision can be a safe alternative to more radical surgery in carefully selected patients, helping to reduce morbidity while maintaining oncological outcomes. Pocard also critically evaluates emerging technologies, as seen in his work questioning the routine adoption of robotic right colectomy, emphasizing that feasibility does not always equate to clinical benefit. His research has shaped modern colorectal surgery by balancing oncologic radicality with quality of life, making him a key figure in the field. With a career spanning numerous clinical trials and guidelines, Pocard continues to influence surgical decision-making for rectal cancer worldwide.

Research Focus

Key Achievements

2
H-Index
2
Papers
19
Total Citations
10
Avg Citations/Paper
🏆 Most Cited Paper
Local Excision Versus Total Mesorectal Excision in Patients with Good Response After Neoadjuvant Radiochemotherapy for T2-T3 Low Rectal Cancer: Preliminary Results of the GRECCAR 2 Randomized Phase 3 Trial
14 citations · 2014
📈 Most Prolific Year: 2014 (1 Papers)
🤝 Key Collaborators: 19
🏛 Institutions: Hôpital Lariboisière, Sorbonne Université

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago